A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1994
11/29/1994	US5368868 Nonionic surfactants of ethylene propylene oxide copolymers
11/29/1994	US5368865 Suspendible composition and process for preparing the same
11/29/1994	US5368864 Formulation of oxypurinol and/or its alkali and alkaline earth salts
11/29/1994	US5368860 Preparation for transdermal drug administration
11/29/1994	US5368859 Biodegradable system for regenerating the periodontium
11/29/1994	US5368853 Leukoregulin anti-viral therapy
11/29/1994	US5368852 Prolonged-release liquid type of pharmaceutical preparation comprising drug-resin complex and benzoate preservative
11/29/1994	US5368844 Antiplaque, antigingivitis, anticaries oral composition
11/29/1994	US5368841 Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
11/29/1994	CA2124402A1 Use of o-esters of l-carnitine for producing pharmaceutical compositions for the treatment of dermatoses
11/29/1994	CA2124382A1 14.alpha.-hydroxy-4-androstene-3,6,17-trione hydrate crystal and process for producing same
11/29/1994	CA2124252A1 Method of reducing or preventing bone marrow hypoplasia
11/29/1994	CA2021282C Dispenser comprising ionophore
11/29/1994	CA1333285C Morpholinoethylester of mycophenolic acid and derivatives thereof
11/29/1994	CA1333265C Coupling agents for radiolabeling proteins
11/29/1994	CA1333257C Use of zinc hydroxide or iron hydroxide as adjuvant in antigen solutions, and antigen solutions containing such adjuvants
11/28/1994	CA2124289A1 2-hydroxy-3-¬1-(1h-imidazol-4-yl)alkyl\|-benzenecarboximidamides
11/28/1994	CA2124277A1 Methods for administering biological agents and microparticle compositions useful in these and other methods
11/27/1994	CA2124054A1 Octacyclodepsipeptides having an endoparasiticidal action
11/26/1994	CA2124057A1 Substituted 2,4-imidazolidinediones
11/26/1994	CA2122886A1 Saccharin derivative proteolytic enzyme inhibitors
11/25/1994	CA2124048A1 Aryl substituted heterocycles
11/25/1994	CA2123534A1 Rafting antacid formulation
11/24/1994	WO1994026921A1 Production of toxin binding biopolymers, use thereof
11/24/1994	WO1994026915A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	WO1994026914A1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/24/1994	WO1994026888A1 Inhibition of proliferation of vascular smooth muscle cell
11/24/1994	WO1994026887A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same
11/24/1994	WO1994026877A1 Ribozyme gene therapy for hiv infection and aids
11/24/1994	WO1994026769A1 Anti-inflammatory compounds for ophthalmic use
11/24/1994	WO1994026768A1 Osteogenesis promoter and osteoporosis remedy
11/24/1994	WO1994026767A1 Improved antiandrogens
11/24/1994	WO1994026760A1 SIALYL Lex ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
11/24/1994	WO1994026759A1 Selectin receptor modulating compositions
11/24/1994	WO1994026754A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
11/24/1994	WO1994026750A1 Deoxythiomarinol derivatives, process and intermediates for their preparation and their use as microbicides and herbicides
11/24/1994	WO1994026747A1 Ampa antagonists and a method of treatment therewith
11/24/1994	WO1994026746A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE
11/24/1994	WO1994026745A1 Fibrinogen receptor antagonists
11/24/1994	WO1994026744A1 8-substituted xanthines as selective adenosine receptor agents
11/24/1994	WO1994026740A1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists
11/24/1994	WO1994026739A1 1,4-benzoxazine derivatives as potassium channel openers
11/24/1994	WO1994026738A1 N'-heterocyclyl-n-benzofuranyl urea derivatives and their analogs as acat inhibitors
11/24/1994	WO1994026736A1 Thioindole pyperidinyl derivatives used as antalgics
11/24/1994	WO1994026735A1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
11/24/1994	WO1994026733A1 Pyrimidine derivatives
11/24/1994	WO1994026732A1 Carbostyril derivatives
11/24/1994	WO1994026730A2 Novel aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
11/24/1994	WO1994026728A1 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use
11/24/1994	WO1994026725A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
11/24/1994	WO1994026723A2 ras FARNESYL TRANSFERASE INHIBITORS
11/24/1994	WO1994026719A1 Mercapto-amide derivatives useful as neutral endopeptidase and ace inhibitors
11/24/1994	WO1994026717A1 Hiv protease inhibitors useful for the treatment of aids
11/24/1994	WO1994026714A1 Novel deoxygalactonojirimycin derivatives
11/24/1994	WO1994026713A1 DERIVATIVES OF β, β-DIMETHYL-4-PIPERIDINEETHANAMINE AS INHIBITORS OF THE CHOLESTEROL BIOSYNTHESIS
11/24/1994	WO1994026712A1 4-(4-fluorophenylmethyl)-piperidines having sigma and d2-receptor affinity
11/24/1994	WO1994026710A1 INDOLE DERIVATIVES AS TESTOSTERONE 5α-REDUCTASE INHIBITORS
11/24/1994	WO1994026709A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+/H+ EXCHANGE IN CELLS
11/24/1994	WO1994026708A1 Optically active 3-(1-(alkylamino))alkyl pyrrolidines
11/24/1994	WO1994026707A1 Vitamin d amide derivatives
11/24/1994	WO1994026704A1 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease
11/24/1994	WO1994026702A1 N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
11/24/1994	WO1994026695A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
11/24/1994	WO1994026693A1 Bicyclic amide derivatives and their use as muscle relaxants
11/24/1994	WO1994026692A1 Bicyclic amide derivatives and their use as muscle relaxants
11/24/1994	WO1994026322A1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant
11/24/1994	WO1994026314A1 Compounds for cancer imaging and therapy
11/24/1994	WO1994026312A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE
11/24/1994	WO1994026310A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
11/24/1994	WO1994026307A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	WO1994026303A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
11/24/1994	WO1994026291A1 Therapeutic inhibitor of vascular smooth muscle cells
11/24/1994	WO1994026283A1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases
11/24/1994	WO1994026282A1 Methods for treating pathologies
11/24/1994	WO1994026281A1 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
11/24/1994	WO1994026280A1 Remedy for arthritis containing uridine as active ingredient
11/24/1994	WO1994026279A1 Bisphosphonate esters for treating gastric disorders
11/24/1994	WO1994026278A1 Aurintricarboxylic acid fractions and analogues with anti-angiogenic activity and methods of use
11/24/1994	WO1994026277A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
11/24/1994	WO1994026274A1 Treatment process with biologically active tropane derivatives
11/24/1994	WO1994026273A1 Acyclovir derivatives for topical use
11/24/1994	WO1994026272A1 3-[n-(2-mercapto-propionyl-amino-acetyl)]-tetrahydro-thiazolyl-4-carboxylic acid as antiinflammatory and immunostimulating agent
11/24/1994	WO1994026271A1 Treatment of cryptococcus neoformans infection
11/24/1994	WO1994026270A1 Transdermal therapeutic systems for the administration of serotonin agonists
11/24/1994	WO1994026269A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
11/24/1994	WO1994026268A1 Methods and compositions using optically pure (+)-zileuton
11/24/1994	WO1994026267A1 Compositions in the form of solid solutions
11/24/1994	WO1994026266A1 High dose formulations
11/24/1994	WO1994026265A1 16-hydroxytriptolide composition and method for immunotherapy
11/24/1994	WO1994026263A2 Use of a transition metal complex for the treatment of septic shock
11/24/1994	WO1994026262A1 Inhibition of expression of beta-lactamase using esters of fatty acid alcohols
11/24/1994	WO1994026261A1 Treating body parts susceptible to ischemia using creatine analogs
11/24/1994	WO1994026260A1 METHODS AND COMPOUNDS FOR INHIBITING CELL PROLIFERATIVE DISORDERS CHARACTERIZED BY ABNORMAL abl ACTIVITY
11/24/1994	WO1994026259A1 Chemical prevention or reversal of cataract by phase separation inhibitors
11/24/1994	WO1994026258A1 Oral compositions containing triclosan for the treatment of aphthous ulcers
11/24/1994	WO1994026257A1 Transdermal therapeutic system containing estradiol
11/24/1994	WO1994026254A1 Incorporation of taxol into liposomes and gels
11/24/1994	WO1994026250A1 Method for treating neurological disorders
11/24/1994	WO1994026249A1 Compositions and methods for reparation and prevention of fibrotic lesions
11/24/1994	WO1994026243A1 Oral compositions

1 ... 7063 7064 7065 7066 7067 7068 7069 7070 7071 7072 7073 7074 7075 7076 7077 7078 7079 7080 7081 7082 7083 ... 7860